Jesús San Miguel
Jesús San Miguel
Director Médico de la Clínica Universidad de Navarra
No verified email - Homepage
Cited by
Cited by
International uniform response criteria for multiple myeloma
BGM Durie, JL Harousseau, JS Miguel, J Blade, B Barlogie, K Anderson, ...
Leukemia 20 (9), 1467-1473, 2006
International staging system for multiple myeloma
PR Greipp, JS Miguel, BGM Durie, JJ Crowley, B Barlogie, J Bladé, ...
Journal of clinical oncology 23 (15), 3412-3420, 2005
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson, P Sonneveld, MW Schuster, D Irwin, EA Stadtmauer, ...
New England journal of medicine 352 (24), 2487-2498, 2005
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
JF San Miguel, R Schlag, NK Khuageva, MA Dimopoulos, O Shpilberg, ...
New England Journal of Medicine 359 (9), 906-917, 2008
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
International Myeloma Working Group
British journal of haematology 121 (5), 749-757, 2003
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
M Dimopoulos, A Spencer, M Attal, HM Prince, JL Harousseau, ...
New England Journal of Medicine 357 (21), 2123-2132, 2007
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
XS Puente, M Pinyol, V Quesada, L Conde, GR Ordóñez, N Villamor, ...
Nature 475 (7354), 101-105, 2011
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
JJM Van Dongen, EA Macintyre, JA Gabert, E Delabesse, V Rossi, ...
Leukemia 13 (12), 1901-1928, 1999
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
AK Stewart, SV Rajkumar, MA Dimopoulos, T Masszi, I Špička, A Oriol, ...
New England Journal of Medicine 372 (2), 142-152, 2015
Elotuzumab therapy for relapsed or refractory multiple myeloma
S Lonial, M Dimopoulos, A Palumbo, D White, S Grosicki, I Spicka, ...
New England Journal of Medicine 373 (7), 621-631, 2015
Revised international staging system for multiple myeloma: a report from International Myeloma Working Group
A Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ...
Journal of clinical oncology 33 (26), 2863, 2015
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The lancet oncology 17 (8), e328-e346, 2016
Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
RG Owen, SP Treon, A Al-Katib, R Fonseca, PR Greipp, ML McMaster, ...
Seminars in oncology 30 (2), 110-115, 2003
Daratumumab, lenalidomide, and dexamethasone for multiple myeloma
MA Dimopoulos, A Oriol, H Nahi, J San-Miguel, NJ Bahlis, SZ Usmani, ...
New England Journal of Medicine 375 (14), 1319-1331, 2016
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute …
P Fenaux, C Chastang, S Chevret, M Sanz, H Dombret, E Archimbaud, ...
Blood, The Journal of the American Society of Hematology 94 (4), 1192-1200, 1999
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hajek, ...
Leukemia 23 (2), 215-224, 2009
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma
A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ...
Leukemia 22 (2), 414-423, 2008
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
SV Rajkumar, JL Harousseau, B Durie, KC Anderson, M Dimopoulos, ...
Blood 117 (18), 4691-4695, 2011
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label …
J San Miguel, K Weisel, P Moreau, M Lacy, K Song, M Delforge, L Karlin, ...
The lancet oncology 14 (11), 1055-1066, 2013
The system can't perform the operation now. Try again later.
Articles 1–20